For rate control, diltiazem is preferred in COVID-19 patients as beta-blockers may precipitate bronchospasm in respiratory disease [10]
4% of the population, have received at least one dose of the COVID-19 vaccine, with 230
Of 61 completers from both studies, 47 received ≥1 dose of a COVID-19 vaccine
New study using the American Heart Association’s COVID-19 Cardiovascular
As the coronavirus 2019 (COVID-19) pandemic marches unrelentingly, more patients with cardiac arrhythmias are emerging due to the effects of the virus on the
GVDN researchers concluded that the COVID-19 vaccine was linked to a small increase in heart, blood, and brain disorders
Our finding suggests that diltiazem has potential as a drug against SARS-CoV-2 infection and that Ca v 1
These vaccines have excellent safety profiles with few reported side effects
COVID-19 vaccines are safe and effective
This has caused increased financial and socioeconomic hardship in households and hospital systems worldwide []
Medications to treat high blood pressure did not affect outcomes among patients hospitalized with COVID-19, found an international team led by researchers in
The higher rate of facial involvement and a lower positive rate of anti-ganglioside antibodies may be a characteristic feature of GBS following COVID-19
Specifically, research has also found a causal link between
Novavax COVID-19 Vaccine, Adjuvanted: On July 13, 2022, the FDA reauthorized emergency use of this two-dose vaccine series for people age 12 and older
A higher-than-usual number of cases of a type of heart inflammation has been reported following Covid-19 vaccination, especially among young men Side effects
This vaccine is available for people age 6 months and older
COVID-19 vaccines help our bodies develop immunity to the virus that causes COVID-19 without us having to get the illness
Patients who were vaccinated against COVID-19 have experienced thrombosis-thrombocytopenia syndrome and cerebral venous sinus thrombosis (CVST)
However, COVID-19 vaccines are known to cause new-onset or relapsing glomerular diseases due to potent immune dysregulation, and various therapeutic responses have been reported [ 4, 5 ]
The COVID-19 vaccine lessens the severity of COVID-19 by teaching the immune system to recognize and fight the virus that causes the disease